Clinical Trial Update: Minimally Invasive Coronary Artery Bypass Supported by Cangrelor

View source ↗

Summary

This clinical trial update describes ongoing recruitment for a minimally invasive coronary artery bypass procedure supported by the antiplatelet drug cangrelor.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cangrelor (cangrelor)

Snippet

Sponsor: Cardiocentro Ticino | Conditions: Coronary Artery Disease, Antiplatelet Therapy | Status: RECRUITING